← Leaderboards
Kathleen Ann Martin
Yale University
$14,895,788
Attributed
$16,973,729
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,973,729 · 10
By mechanism
R01$16,933,729 · 8
R13$40,000 · 2
Top collaborators
- Patrick G Gallagher4 shared
- Daniel Greif3 shared
Most similar at Yale University
Same institution · by research overlap
- Daniel Greif$13,277,104
- Don X Nguyen$10,390,286
- John C Stendahl$648,420
- Karthik Murugiah$664,768
- Michael Simons$49,269,368
Others in their field
Top investigators on “Cardiovascular Diseases”
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$145,558,149
- Judith S. Currier · University Of California Los Angeles$143,001,230
- David M Nathan · Massachusetts Institute Of Technology$141,671,512
- John M Lachin · George Washington University$139,991,329
- Judith S Hochman · New York University School Of Medicine$112,514,057
Research focus
Cardiovascular DiseasesSmooth Muscle MyocytesPhenotypeAtherosclerosisGene ExpressionBlood VesselsResponseInjuryCell Differentiation ProcessIn VivoHyperplasiaGenesPathway InteractionsEpigenetic ProcessProteinsAngioplastyMyocardinIn VitroKnock-OutTransplantationGrowthPreventSirolimusRegulation
Grant awards (36)
Heterochromatin dynamics in vascular smooth muscle plasticity$756,224
R01 · FY2025 · HL · contact PI
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy$654,729
R01 · FY2025 · HD
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy$648,182
R01 · FY2024 · HD
Epigenetic-mediated Notch pathway activation promotes elastin aortopathy$654,729
R01 · FY2023 · HD
Role of LMO7 in atherosclerosis$534,519
R01 · FY2023 · HL · contact PI
Vascular Discovery, From Genes to Medicine 2023$20,000
R13 · FY2023 · HL · contact PI
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2$548,500
R01 · FY2022 · HL · contact PI
Role of LMO7 in atherosclerosis$534,519
R01 · FY2022 · HL · contact PI
2022 Vascular Discovery: From Genes to Medicine$20,000
R13 · FY2022 · HL · contact PI
Novel insights into intimal hyperplasia in cardiac allograft vasculopathy$603,930
R01 · FY2021 · HL · contact PI
Role of LMO7 in atherosclerosis$568,019
R01 · FY2021 · HL · contact PI
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2$548,500
R01 · FY2021 · HL · contact PI
Novel insights into intimal hyperplasia in cardiac allograft vasculopathy$603,930
R01 · FY2020 · HL · contact PI
Role of LMO7 in atherosclerosis$568,019
R01 · FY2020 · HL · contact PI
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2$548,500
R01 · FY2020 · HL · contact PI
Novel insights into intimal hyperplasia in cardiac allograft vasculopathy$603,930
R01 · FY2019 · HL · contact PI
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2$552,743
R01 · FY2019 · HL · contact PI
Novel insights into intimal hyperplasia in cardiac allograft vasculopathy$603,930
R01 · FY2018 · HL · contact PI
Novel Targets of Rapamycin & Akt in VSMC Differentiation$416,250
R01 · FY2017 · HL · contact PI
Epigenetic control of vascular smooth muscle in cardiovascular disease$416,250
R01 · FY2017 · HL · contact PI
Regulation of vascular smooth muscle cell plasticity$416,250
R01 · FY2017 · HL · contact PI
Regulation of vascular smooth muscle cell plasticity$416,250
R01 · FY2016 · HL · contact PI
Novel Targets of Rapamycin & Akt in VSMC Differentiation$416,250
R01 · FY2016 · HL · contact PI
Epigenetic control of vascular smooth muscle in cardiovascular disease$416,250
R01 · FY2016 · HL · contact PI
Novel Targets of Rapamycin & Akt in VSMC Differentiation$410,006
R01 · FY2015 · HL · contact PI
Epigenetic control of vascular smooth muscle in cardiovascular disease$410,006
R01 · FY2015 · HL · contact PI
Regulation of vascular smooth muscle cell plasticity$410,006
R01 · FY2015 · HL · contact PI
Regulation of vascular smooth muscle cell plasticity$416,250
R01 · FY2014 · HL · contact PI
Epigenetic control of vascular smooth muscle in cardiovascular disease$416,250
R01 · FY2014 · HL · contact PI
Novel Targets of Rapamycin & Akt in VSMC Differentiation$407,925
R01 · FY2014 · HL · contact PI
Novel Targets of Rapamycin & Akt in VSMC Differentiation$396,270
R01 · FY2013 · HL · contact PI
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation$409,613
R01 · FY2012 · HL · contact PI
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation$413,750
R01 · FY2011 · HL · contact PI
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation$413,750
R01 · FY2010 · HL · contact PI
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation$399,750
R01 · FY2009 · HL · contact PI
Novel targets of rapamycin and Akt in vascular smooth muscle cell differentiation$399,750
R01 · FY2008 · HL · contact PI